» Authors » Jonathan Rubin

Jonathan Rubin

Explore the profile of Jonathan Rubin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 102
Citations 1648
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
31.
Faraone S, Gomeni R, Hull J, Busse G, Melyan Z, Rubin J, et al.
Eur Child Adolesc Psychiatry . 2021 Sep; 32(3):491-499. PMID: 34581911
Improvement in attention-deficit/hyperactivity disorder (ADHD) symptoms vs. placebo was reported in a series of pediatric clinical trials of viloxazine extended-release capsules (viloxazine ER; Qelbree™). This post hoc analysis of those...
32.
Faraone S, Gomeni R, Hull J, Busse G, Melyan Z, Rubin J, et al.
Paediatr Drugs . 2021 Sep; 23(6):583-589. PMID: 34523063
Aim: The aim of this study was to evaluate the effect of viloxazine extended-release capsules (viloxazine ER; Qelbree™) on executive function deficits (EFDs) in pediatric subjects (6-17 years of age)...
33.
Nasser A, Hull J, Liranso T, Busse G, Melyan Z, Childress A, et al.
Neuropsychiatr Dis Treat . 2021 Jun; 17:1751-1762. PMID: 34113106
Purpose: The ADHD Rating Scale (ADHD-RS) assesses 18 symptoms of inattention and hyperactivity/impulsivity and has been used in many clinical trials to evaluate the treatment effect of drugs on ADHD....
34.
Nasser A, Kosheleff A, Hull J, Liranso T, Qin P, Busse G, et al.
Int J Clin Pract . 2021 May; 75(8):e14330. PMID: 33971070
Aims: When clinicians evaluate potential medications for their patients, they must weigh the probability of a treatment's benefits against the possible risks. To this end, the present analyses evaluate the...
35.
Nasser A, Kosheleff A, Hull J, Liranso T, Qin P, Busse G, et al.
J Child Adolesc Psychopharmacol . 2021 Feb; 31(3):214-226. PMID: 33600233
Clinical trials in psychiatry frequently report results from lengthy, comprehensive assessments to characterize a subject emotionally, cognitively, and behaviorally before and after treatment. However, the potential treatment implications of these...
36.
Faraone S, Gomeni R, Hull J, Busse G, Melyan Z, ONeal W, et al.
Psychiatry Res . 2021 Jan; 296:113664. PMID: 33418457
Machine learning (ML) was used to determine whether early response can predict efficacy outcome in pediatric subjects with ADHD treated with SPN-812. We used data from four Phase 3 placebo-controlled...
37.
Parker R, Hogg J, Roy A, Kellum J, Rimmele T, Daun-Gruhn S, et al.
Processes (Basel) . 2020 Nov; 4(4):38. PMID: 33134139
The body responds to endotoxins by triggering the acute inflammatory response system to eliminate the threat posed by gram-negative bacteria (endotoxin) and restore health. However, an uncontrolled inflammatory response can...
38.
Principe D, Koch R, Bergsten T, Rubin J
Oxf Med Case Reports . 2019 Dec; 2019(11):omz140. PMID: 31879565
Neutropenic enterocolitis (NE) is a life-threatening infection of the immunocompromised. NE ubiquitously affects the cecum, often with involvement of the ascending colon and ileum. Classically, NE is associated with high...
39.
Parvaneh S, Rubin J, Babaeizadeh S, Xu-Wilson M
J Electrocardiol . 2019 Aug; 57S:S70-S74. PMID: 31416598
Due to its simplicity and low cost, analyzing an electrocardiogram (ECG) is the most common technique for detecting cardiac arrhythmia. The massive amount of ECG data collected every day, in...
40.
Rubin J, Aggarwal S, Swett K, Kirtane A, Kodali S, Nazif T, et al.
Mayo Clin Proc . 2019 Jul; 94(8):1488-1498. PMID: 31279542
Objective: To explore the burden and clinical correlates of valvular heart disease in Hispanics/Latinos in the United States. Patients And Methods: A total of 1818 individuals from the population-based study...